Related Experiment Video
Updated: Nov 1, 2025

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
Published on: March 31, 2021
Controlled Delivery of MicroRNAs into Primary Cells Using Nanostraw Technology
Mara A Pop1, Benjamin D Almquist1
1Department of Bioengineering, Imperial College, London SW7 2AZ, UK.
This study introduces a novel nanostraw-electroporation platform for precise control over microRNA (miRNA) delivery. This breakthrough allows researchers to explore the dosage-dependent effects of miRNAs on cellular processes, advancing epigenetic research.
Area of Science:
- Epigenetics
- Molecular Biology
- Biotechnology
Background:
- MicroRNAs (miRNAs) are crucial epigenetic regulators of cellular processes.
- The dosage-dependent effects of miRNAs on gene regulation are largely unexplored.
- Current miRNA delivery methods lack precise dosage control.
Purpose of the Study:
- To develop a delivery platform enabling precise control over intracellular miRNA dosage.
- To investigate the dose-dependent effects of miRNAs on cellular responses.
- To demonstrate efficient miRNA delivery into hard-to-transfect cells.
Main Methods:
- Development of a nanostraw-electroporation platform for miRNA delivery.
- Decoupling miRNA delivery from cellular uptake mechanisms like endocytosis.
- Demonstration of ratiometric intracellular delivery of miR-181a and miR-27a into fibroblasts.
- Assessment of miRNA delivery into primary keratinocytes.
Main Results:
- The nanostraw-electroporation platform precisely controls the amount of miRNA delivered intracellularly.
- Ratiometric delivery of specific miRNAs (miR-181a, miR-27a) into dermal fibroblasts was achieved.
- Efficient miRNA delivery into primary keratinocytes, a challenging cell type, was demonstrated.
Conclusions:
- The nanostraw-electroporation platform overcomes limitations of current miRNA delivery systems.
- This technology enables precise investigation of miRNA dosage-dependent gene regulation.
- It opens new avenues for therapeutic applications involving miRNA modulation, particularly in difficult-to-transfect cells.
More Related Videos
09:14High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays MEA
Published on: September 13, 2012
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
Related Concept Videos
Experimental RNAi
MicroRNAs